ZA922464B - Suppression of thromboxane levels by percutaneous administration of aspirin - Google Patents
Suppression of thromboxane levels by percutaneous administration of aspirinInfo
- Publication number
- ZA922464B ZA922464B ZA922464A ZA922464A ZA922464B ZA 922464 B ZA922464 B ZA 922464B ZA 922464 A ZA922464 A ZA 922464A ZA 922464 A ZA922464 A ZA 922464A ZA 922464 B ZA922464 B ZA 922464B
- Authority
- ZA
- South Africa
- Prior art keywords
- suppression
- aspirin
- percutaneous administration
- thromboxane levels
- thromboxane
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001138 acetylsalicylic acid Drugs 0.000 title abstract 2
- 230000001629 suppression Effects 0.000 title abstract 2
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68019591A | 1991-04-03 | 1991-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA922464B true ZA922464B (en) | 1992-12-30 |
Family
ID=24730117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA922464A ZA922464B (en) | 1991-04-03 | 1992-04-03 | Suppression of thromboxane levels by percutaneous administration of aspirin |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0578780B1 (de) |
| JP (1) | JPH06510984A (de) |
| KR (1) | KR100247441B1 (de) |
| AT (1) | ATE244011T1 (de) |
| AU (1) | AU668352B2 (de) |
| CA (1) | CA2107587C (de) |
| DE (1) | DE69233116T2 (de) |
| DK (1) | DK0578780T3 (de) |
| FI (1) | FI934324A0 (de) |
| NO (1) | NO306536B1 (de) |
| WO (1) | WO1992020343A1 (de) |
| ZA (1) | ZA922464B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP921157A2 (en) * | 1991-12-20 | 1994-10-31 | Lohmann Therapie Syst Lts | Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy |
| WO1994013302A1 (de) * | 1991-12-20 | 1994-06-23 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe |
| DE19616539A1 (de) * | 1996-04-25 | 1997-11-06 | Luitpold Pharma Gmbh | Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel |
| TWI243687B (en) | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| JP2000351729A (ja) * | 1999-06-08 | 2000-12-19 | Shionogi & Co Ltd | トロンボキサンａ２受容体拮抗剤の経皮吸収製剤 |
| AR026073A1 (es) | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
| WO2002085376A2 (en) * | 2001-04-19 | 2002-10-31 | Universite De Montreal | A method for decreasing superoxide anion production and for the treatment of diseases associated with oxidative stress |
| WO2011076401A1 (de) | 2009-12-23 | 2011-06-30 | Holger Schankin | Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2295753A1 (fr) * | 1974-12-23 | 1976-07-23 | Despin Jean | Composition a base d'acide acetyl-salicylique a usage topique |
| FR2496459A1 (fr) * | 1980-12-19 | 1982-06-25 | Astier Laboratoires Docteur P | Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique |
| IL68965A (en) * | 1983-06-13 | 1987-02-27 | Rafa Labor Ltd | Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders |
| EP0162239B1 (de) * | 1984-04-23 | 1991-08-07 | Kao Corporation | Perkutaner Absorptions-Beschleuniger und diesen enthaltendes Präparat |
| US4866046A (en) * | 1988-05-31 | 1989-09-12 | Top Laboratories, Inc. | Low-dosage sublingual aspirin |
-
1992
- 1992-04-02 EP EP92912205A patent/EP0578780B1/de not_active Expired - Lifetime
- 1992-04-02 KR KR1019930702972A patent/KR100247441B1/ko not_active Expired - Fee Related
- 1992-04-02 DK DK92912205T patent/DK0578780T3/da active
- 1992-04-02 JP JP4511662A patent/JPH06510984A/ja active Pending
- 1992-04-02 DE DE69233116T patent/DE69233116T2/de not_active Expired - Fee Related
- 1992-04-02 AU AU20142/92A patent/AU668352B2/en not_active Ceased
- 1992-04-02 CA CA002107587A patent/CA2107587C/en not_active Expired - Fee Related
- 1992-04-02 AT AT92912205T patent/ATE244011T1/de not_active IP Right Cessation
- 1992-04-02 WO PCT/US1992/002576 patent/WO1992020343A1/en not_active Ceased
- 1992-04-03 ZA ZA922464A patent/ZA922464B/xx unknown
-
1993
- 1993-10-01 FI FI934324A patent/FI934324A0/fi unknown
- 1993-10-01 NO NO933529A patent/NO306536B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014292A (en) | 1992-12-30 |
| FI934324A0 (fi) | 1993-10-01 |
| CA2107587C (en) | 2004-11-23 |
| DE69233116T2 (de) | 2004-08-26 |
| EP0578780A1 (de) | 1994-01-19 |
| NO933529D0 (no) | 1993-10-01 |
| DE69233116D1 (de) | 2003-08-07 |
| KR100247441B1 (ko) | 2000-04-01 |
| EP0578780B1 (de) | 2003-07-02 |
| NO306536B1 (no) | 1999-11-22 |
| NO933529L (no) | 1993-11-29 |
| AU668352B2 (en) | 1996-05-02 |
| WO1992020343A1 (en) | 1992-11-26 |
| ATE244011T1 (de) | 2003-07-15 |
| DK0578780T3 (da) | 2003-08-18 |
| CA2107587A1 (en) | 1992-10-04 |
| JPH06510984A (ja) | 1994-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3017367T3 (en) | composition in the form of a foam containing 5-aminosalicylic acid for intra-rectal administration. | |
| IE873157L (en) | Controlled absorption ismn containing formulations | |
| HUT65192A (en) | Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino benzazepine derivatives and pharmaceutical preparations containing | |
| EP0449247A3 (en) | Pharmaceutical composition containing galanthamine for treating alcoholism | |
| IL99699A0 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
| HU895286D0 (en) | Process for the preparation of steroid 5alfa-reductase inhibiting compounds and pharmaceutical compositions containing such compounds | |
| PL305092A1 (en) | Novel derivatives of 11-benzaldoxim estradiene, method of obtaining them and therapeutic agents containing such compounds | |
| HUT50038A (en) | Process for producing pharmaceutical compositions preventing or reducing drug addiction | |
| ES8603870A1 (es) | Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol. | |
| IL64091A (en) | Arylimidazo(1,2-a)pyridine acetamide derivatives,their preparation and pharmaceutical compositions containing them | |
| UA19782A (uk) | Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей | |
| ZA922464B (en) | Suppression of thromboxane levels by percutaneous administration of aspirin | |
| ZA9410079B (en) | Methods of increasing thrombomodulin expression | |
| IL88971A0 (en) | Disubstituted pyridines,their preparation and pharmaceutical compositions containing them | |
| IL111580A (en) | Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders | |
| IL111579A (en) | Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders | |
| HUT48119A (en) | Process for producing pharmaceutical compositions against addiction to nicotine and comprising 2-pyrimidinyl-1-piperazine derivatives | |
| GB2162748B (en) | Medicinal composition for the treatment or prevention of acne by oral administration | |
| AU2405292A (en) | Method of producing well tolerated drugs containing human proteins for administration by infusion or injection | |
| NO990283L (no) | Formulering for behandling og/eller profylakse av demens | |
| HUT65256A (en) | Process for producing 2-mercapto methylene-tetrahydronaphtalene-2-carboxamide derivatives and pharmaceutical preparations containing them | |
| IL96161A0 (en) | Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency | |
| EP0621789A4 (en) | Pharmaceutical pentapeptide compositions and methods of use thereof. | |
| ES2165382T3 (es) | Agentes antiateroescleroticos. | |
| HU895452D0 (en) | Process for the preparation of pharmaceutical compositions of new dose form |